Authors



Heide Aungst

Latest:

Niche pharmacies serve children and the elderly

Specialty pharmacies are developing to meet the growing needs of children and senior citizens.


Jill Wechsler

Latest:

User Fees Reauthorized for FDA

FDA keeps its user fees but fails to gain important reforms.


Julia Talsma, Editor-in-Chief

Latest:

Drug Topics CPE accreditor begins 3-year service to AACP

During the American Association of Colleges of Pharmacy (AACP) Annual Meeting in Kissimmee, Fla. in mid-July, Jill Fitzgerald, PharmD, who is Drug Topics CPE accreditor, was sworn in as chair-elect to the AACP Continuing Professional Education Section.



Drug Topics readers

Latest:

Letters

Readers have their say on unionization, fair reimbursement, and self-regulation.



Leah Perry

Latest:

Pipeline drugs 2010

Categories to watch in this year's diverse drug pipeline include oral agents to treat multiple sclerosis and a host of new diabetes, cardiovascular, and pain-management products.


David D. Trang, PharmD, MBA

Latest:

Is the pharmacist shortage over?

Increasing enrollment in pharmacy schools and changing economic factors appear to have eased the national pharmacist shortage. In order to plan appropriately for all stakeholders, we need to quantify the numbers when we talk about a pharmacist shortage.


Ernest P. Gates Jr., RPh, FASCP, FIACP, FACA

Latest:

Opinion: Compounding Pharmacists Must Rebuild the Industry

Four steps that compounding pharmacists must take to restore their credibility.


Michael J. Schuh, BS, PharmD, MBA

Latest:

A retail pharmacist examines the consequences of working in a fishbowl

Doctors don't do it. Attorneys don't do it. Physical therapists, insurance agents, title agents, audiologist, and nurse practitioners don't do it. Who came up with the fishbowl model of retail pharmacy anyway?


Ken Krizner

Latest:

Top Challenges in Managing Diabetes

Cost, education, self-monitoring, and more. 


Christine Blank

Latest:

Continuous Glucose Monitors Useful for Predicting Pre-Diabetes

When employed as a prescreening tool, care must be taken to avoid overdiagnosis of healthy individuals without diabetes.


Ron Rajecki

Latest:

Drug Topics' 2010 business outlook survey

Respondents to this year's business outlook survey are generally upbeat about the business their pharmacies are doing and their prospects for the coming year.


From staff reports

Latest:

FDA warns against prolonged use of magnesium sulfate to stop preterm labor

FDA advised healthcare professionals not to use magnesium sulfate injection for more than 5-7 days to stop preterm labor in pregnant women.


B. Douglas Hoey, RPh, MBA

Latest:

Opinion: PBM Hocus Pocus Harming Seniors, Small Business Pharmacies

Policymakers have the power to get pharmacy benefit managers under control.



Fred Gebhart

Latest:

Launch Your Own Diabetes Prevention Program

The CDC estimates that 83 million Americans have prediabetes and that 84% of them don’t know it and community pharmacy can play a major role in preventing diabetes.



Keith W. Trettin, RPh, MBA

Latest:

Drug delivery systems: Multiple- vs. single-dose

All hospital and health systems must decide whether to use multiple-dose vials or single-dose vials of drugs, a decision that usually rests on two considerations: Cost reduction and patient safety. The pros and cons of the two systems lead to an inescapable conclusion.


James M. Scanlon, BS, RPh

Latest:

Problem-solving in the pharmacy

Confronted with these three common scenarios in your daily practice of pharmacy, what would you do?


Mari Edlin

Latest:

Collaborative practice agreements

When pharmacists manage drug therapy for physicians, diabetes patients see a significant improvement in key measures.


Marvin Moore, PharmD

Latest:

How to Talk About Being a Pharmacist

When someone asks about your job, how do you answer?


From staff reports

Latest:

Immunizations without prescriptions available at some Good Neighbor pharmacies

Good Neighbor Pharmacy stores in 19 states are now providing immunization services to patients without doctor’s prescriptions.


Drug Topics staff

Latest:

Drug Topics Top 10: Most Read Stories From April 2024

Check out this list of our 10 most read stories from April 2024.


Michele B. Kaufman, PharmD, RPh

Latest:

Oral oncology drugs

The management of oral oncology drugs is an unending series of responsibilities involving safety issues, billing requirements, patient needs, prescriber details, and reimbursement challenges.


Jeffrey Bendix, Senior Editor

Latest:

COVID-19 Vaccination Rates More Sluggish in Children Than Adults

Study links discrepancy to adults’ misbeliefs about vaccine safety


Ellen Whipple Guthrie, PharmD

Latest:

R.Ph. named director of UConn's Evidence-based Practice Center

The Agency for Healthcare Research and Quality in the Department of Health and Human Services recently awarded the University of Connecticut a 5-year contract and up to $1 million per year to establish a new Evidence-based Practice Center.


L.D. King

Latest:

FDA's stand on compounding is bad for R.Ph.s and patients

A compounding leader takes issue with FDA's position that compounding is the production of a new drug that needs to be approved.


Bruce T. Roberts, RPh

Latest:

Drug prices can't depend on who's buying

In the prescription drug market, discriminatory pricing is common for independent community pharmacies and their patients. This fall, a Federal District Court in New York will consider a critical case: Drug Mart Pharmacy Corp. et a. v. American Home Products Corp. et al. The outcome of the case may determine whether discriminatory pricing techniques are illegal.

© 2024 MJH Life Sciences

All rights reserved.